Alfred D Nelson*, Bijan Eghtesad and Jamile’ Wakim-Fleming
Department of Gastroenterology and Hepatology, Cleveland Clinic, USAFulltext PDF
Clostridium difficile Infections (CDI) is increasing in recipients of Solid Organ Transplant (SOT). These patients are at a particularly elevated risk due to comorbid conditions, lengthy hospital stays, recurrent use of antibiotics and immunosuppressive status. CDI are more challenging to diagnose in this group of patients and contribute to a significantly increased mortality, morbidity and recurrence. Preventive measures and early diagnosis remain key in the management of CDI in transplant recipients in order to abort the associated complications.
Clostridium difficile; Solid organ transplant; Antibiotic stewardship; Vaccination
Nelson AD, Eghtesad B, ’ Wakim-Fleming J. Update on Clostridium difficile Infection in Patients with Solid Organ Transplantation. Ann Digest Liver Dis. 2018; 1(3): 1012.